• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Research and Markets: Anaplastic Thyroid Cancer Therapeutics Pipeline Review 2014 - 7 Companies & 11 Drug profiles

    Research and Markets: Anaplastic Thyroid Cancer Therapeutics Pipeline Review 2014 - 7 Companies & 11 Drug profiles

  2. Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy

    Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy

  3. Oncolytics Biotech® Inc. Announces Overall and KRAS-Mutated Patient Data from U.S. Randomized Phase 2 Pancreatic Cancer Study

    Oncolytics Biotech® Inc. Announces Overall and KRAS-Mutated Patient Data from U.S. Randomized Phase 2 Pancreatic Cancer Study

  4. /C O R R E C T I O N from Source -- Oncolytics Biotech Inc./

    /C O R R E C T I O N from Source -- Oncolytics Biotech Inc./

  5. Media Advisory - Oncolytics Biotech® Inc. to Participate in the Baird 2014 Health Care Conference

    Media Advisory - Oncolytics Biotech® Inc. to Participate in the Baird 2014 Health Care Conference

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.